Oncological outcome after laparoscopic ‘no-touch’ versus ‘touch’ left pancreatectomy for pancreatic adenocarcinoma

Author:

Mazzotta Alessandro1,Bodegraven EA2,Usai S.1,Carneiro A. Costa1,Tribillon E.1,Ferraz JM1,Bonnet S.1,Busch O. R.2,Gayet B.1,Besselink MG2,Soubrane O.1

Affiliation:

1. Institut Mutualiste Montsouris

2. Amsterdam UMC, location University of Amsterdam

Abstract

Abstract Background: The validity of laparoscopic distal pancreatectomy in left-sided pancreatic adenocarcinoma (PDAC) is still unclear. However, a meticulous surgical dissection through a “no-touch” technique might allow a radical oncological resection with minimal risk of tumor dissemination and seeding. This study aims to evaluate the oncological outcomes of the laparoscopic “no touch” technique versus the “touch” technique Methods: From 2001 to 2020, we analyzed retrospectively 45 patients undergoing LDP (laparoscopic distal pancreatectomy) for PDAC from two centers. Factors associated with overall (OS), disease-free (DFS) survival and Time to recurrence (TTR) were identified. Results. The OS rates in the ‘no-touch’ and ‘touch’ groups were 95% vs 78% (1-year OS); 50% vs 50% (3-year OS), respectively (p=0.60). The DFS rates in the ‘no-touch’ and ‘touch’ groups were 72 % vs 57 % (1-year DFS); 32% vs 28 % (3-year DFS), respectively (p=0.11). The TTR rates in the ‘no-touch’ and ‘touch’ groups were 77 % vs 61 % (1-year TTR); 54% vs 30 % (3-year TTR); 46% vs 11 % (5-year TTR); respectively (p=0.02) In multivariate analysis the only factors were Touch technique (OR= 2.62, p= 0.02) and lymphovascular emboli (OR= 4.8; p=0.002). Conclusion. We advise the ‘no-touch’ technique in patients with resectable PDAC in the pancreatic body and tail. Although this study does not provide definitive proof of superiority, no apparent downsides are present for the ‘no-touch’ technique in this setting although there could be oncological benefits.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3